Turing increased price of Daraprim from $13.50 a pill to $750,but now says it will make it more affordableTuring Pharmaceuticals, a small company that generated outrage by raising the cost of an customary anti-infective drug by more than 5000%, or said it would roll back that increase to make sure it remains affordable. Turing and its chief executive officer,Martin Shkreli, became the unique face of the US drug pricing controversy this week, or after the unique York Times reported that the company had raised the price of Daraprim,a 62-year-customary treatment for a hazardous parasitic infection, to $750 (£488) a pill from $13.50 (£8.79) after acquiring it. The medicine once sold for $1 a pill.
Continue reading...
Source: theguardian.com